[1]American Diabetes Association. Management of diabetes in pregnancy: standards of medical care in diabetes-2021[J]. Diabetes Care, 2021,44(Suppl 1):S200-200S210. DOI: 10.2337/dc21-S014.
[2]Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis[J]. Am J Obstet Gynecol, 2018,218(3):287-293.e1. DOI: 10.1016/j.ajog.2017.11.561.
[3]Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia[J]. N Engl J Med, 2017,377(7):613-622. DOI: 10.1056/NEJMoa1704559.
[4]Hoffman MK, Goudar SS, Kodkany BS, et al. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial[J]. Lancet, 2020,395(10220):285-293. DOI: 10.1016/S0140-6736(19)32973-3.
[5]Vounzoulaki E, Khunti K, Abner SC, et al. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis[J]. BMJ, 2020,369:m1361. DOI: 10.1136/bmj.m1361.